WSJ Opinion Documentary: During the COVID-19 pandemic, a group of prominent scientists challenged the prevailing government approach to lockdowns. The Lockdown Dissidents tells the story of ...

MSTR holds 818,334 Bitcoin and trades below book value near its 52-week low of $82, yet 13 of 14 analysts rate it a Buy. MSTR's 0.91 price-to-book undercuts miner MARA's 1.25 and rivals Coinbase's $35 ...

The crypto market got a shock on June 1 when Strategy (Nasdaq: MSTR), née MicroStrategy, announced its first Bitcoin (BTC) sale in years. Even though the co-founder Michael Saylor had hinted about the ...

Lepard is personally buying MSTR, targeting $1,000 for the stock that now trades near $128, down 67% over the past year. Lepard warns Saylor either becomes the world's richest man or goes bankrupt ...

👉 Learn how to graph exponential functions involving horizontal shift. An exponential function is a function that increases rapidly as the value of x increases. To graph an exponential function, it ...

👉 Learn how to find the inverse of a function. The inverse of a function is a function that reverses the "effect" of the original function. One important property of the inverse of a function is that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

There seems to be no stop for MicroStrategy's Bitcoin (BTC) shopping. Every week, there is at least one purchase. In fact, at press time, MicroStrategy, now better known as Strategy (NASDAQ: MSTR), ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. David Chisnall discusses how the CHERI ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...